Cerebras Systems Inc. Class A Common StockSecured multi-billion-dollar compute deal with OpenAI and partnership with GlaxoSmithKline, driving demand for its AI inference chips.

Cerebras Systems is emerging as a leader in AI inference, leveraging its single-silicon Wafer-Scale Engine to eliminate communication bottlenecks found in multi-GPU clusters. The company’s WSE-3 chip can deliver 1,800 tokens per second, making it well-suited for real-time voice, live translation, and multi-step agentic workflows. Cerebras has secured a multi-billion-dollar compute deal with OpenAI and a partnership with GlaxoSmithKline for drug research, alongside strategic ties with Amazon, Advanced Micro Devices, and CrowdStrike. Wall Street expects annual revenue to surge from roughly $850 million in 2026 to about $3 billion in 2027. Shares recently cleared the 50-day moving average for the first time, forming a bullish IPO U-Turn base.
Cerebras Systems Inc. Class A Common StockSecured multi-billion-dollar compute deal with OpenAI and partnership with GlaxoSmithKline, driving demand for its AI inference chips.
Advanced Micro Devices Inc
Amazon.com Inc
Crowdstrike Holdings Inc
Meta Platforms Inc.
NVIDIA Corporation
GSK plc